Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Interstitial Lung Disease Clinical Trials
Interstitial Lung Disease clinical trials are recruiting across 131 cities. Here are the cities with the most active studies:
Interstitial Lung Disease Trial Phases
68 research organizations are sponsoring interstitial lung disease trials.
About Interstitial Lung Disease
Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.
Clinical trials are advancing new treatments for interstitial lung disease. Currently, 100 studies are recruiting a combined 357,384 participants across the United States. Research is being conducted by 68 organizations including University of California, San Francisco, Milton S. Hershey Medical Center, St. Jude Children's Research Hospital and 65 others.
2026 Interstitial Lung Disease Research Landscape
As of July 2026, the interstitial lung disease clinical trial landscape includes 100 actively recruiting studies across 131 cities in the United States. These studies are collectively seeking 357,384 participants, with an average enrollment target of 3,574 per study.
The research spans multiple phases of development: 60 studies are in NA, 7 studies are in PHASE3, 5 studies are in PHASE2. The presence of Phase 3 trials indicates that some interstitial lung disease treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 68 different organizations, including University of California, San Francisco, Milton S. Hershey Medical Center, St. Jude Children's Research Hospital, Boston Children's Hospital, Pulmonary Fibrosis Foundation, and 63 others. The large number of sponsors reflects significant research interest and investment in interstitial lung disease treatment advancement.
Geographically, interstitial lung disease trials are most concentrated in Los Angeles, California (12 trials); Aurora, Colorado (11 trials); Philadelphia, Pennsylvania (9 trials); Houston, Texas (9 trials); Chicago, Illinois (8 trials) and 7 other cities.
Featured Interstitial Lung Disease Studies
Highlighted recruiting studies for interstitial lung disease, selected by enrollment size and research scope.
TabCAT Brain Health Assessment in Primary Care
Efficient and user-friendly paradigms to detect cognitive impairment, including dementia are needed in primary care. The TabCAT Brain Health Assessment accurately detects cognitive impairment via an appealing tablet interface with automated scoring and EMR integration. This study will evaluate the effectiveness of the paradigm on detection rates and other brain health outcomes via a pragmatic clus...
iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
Phase 1 was a randomized control trial that used a test-retest model to evaluate the impact of iLook Out for Child Abuse, an online, interactive learning module about reporting suspected child abuse. Delivered via a learning management system to early childhood professionals who work with infants and young children, this study assessed iLookOut's effect on 1) knowledge about reporting suspected ch...
Protocol For Collecting Data On Patients With Childhood Cancer
Progress in the development of curative therapy for pediatric malignancies has resulted in increasing numbers of long-term childhood cancer survivors. This protocol is a means to provide continuing review of outcome and late toxicity for all patients actively being treated and previously treated for childhood cancer at St. Jude Children's Research Hospital.
Frequently Asked Questions About Interstitial Lung Disease Clinical Trials
Are there interstitial lung disease clinical trials near me?
Yes, there are 100 interstitial lung disease clinical trials currently recruiting across 131+ cities in the United States, including Los Angeles, California; Aurora, Colorado; Philadelphia, Pennsylvania. Browse the studies above to find one at a location convenient for you.
How do I join a interstitial lung disease clinical trial?
To join a interstitial lung disease clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are interstitial lung disease clinical trials free?
Yes, participation in interstitial lung disease clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of interstitial lung disease treatments are being studied?
Current interstitial lung disease clinical trials are testing a range of approaches across NA (60 studies), PHASE3 (7 studies), PHASE2 (5 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 68 research organizations.
Is it safe to participate in interstitial lung disease clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 15, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 15, 2026 · Data from ClinicalTrials.gov